Viewing StudyNCT06323382



Ignite Creation Date: 2024-05-06 @ 8:17 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06323382
Status: RECRUITING
Last Update Posted: 2024-03-21
First Post: 2024-03-15

Brief Title: Locoregional Therapy Combined With Bevacizumab and PD1L1 Inhibitor in Advanced Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Advanced Hepatocellular Carcinoma
Anti-PD1PDL1 Antibody
Bevacizumab
Keywords:
Name View
Bevacizumab View
Atezolizumab View
Tislelizumab View
Toripalimab View
Sintilimab View
Camrelizumab View